Eubel Brady & Suttman Asset Management Inc. Acquires 149 Shares of UnitedHealth Group Incorporated $UNH

Eubel Brady & Suttman Asset Management Inc. increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.9% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,087 shares of the healthcare conglomerate’s stock after buying an additional 149 shares during the period. Eubel Brady & Suttman Asset Management Inc.’s holdings in UnitedHealth Group were worth $339,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Glass Jacobson Investment Advisors llc increased its position in shares of UnitedHealth Group by 80.9% during the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after purchasing an additional 55 shares in the last quarter. Kentucky Trust Co increased its position in shares of UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Finally, O Brien Wealth Partners LLC increased its position in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $368.74 on Wednesday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $333.95 billion, a price-to-earnings ratio of 15.98, a PEG ratio of 2.37 and a beta of 0.47. The firm’s fifty day moving average is $340.88 and its two-hundred day moving average is $332.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the company earned $7.15 earnings per share. The firm’s revenue was up 12.2% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Robert W. Baird reissued an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, Sanford C. Bernstein upped their target price on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $389.29.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.